Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Al Gore vs George Bush: the moderate's perspective -- Ignore unavailable to you. Want to Upgrade?

To: long-gone who wrote (4027)	10/30/2000 8:40:43 AM
From: ColtonGang	Read Replies (1) \| Respond to of 10042

THE FACTS>>>>>>>>>>>>Who are the manufacturers licensed to distribute influenza vaccine in the U.S.? The four companies are Parkedale Pharmaceuticals, Inc., Rochester, Michigan; Wyeth-Ayerst Laboratories, Inc., Marietta, Pennsylvania; Aventis Pasteur, Swiftwater, Pennsylvania; and Medeva Pharma Ltd., United Kingdom. What is the cause of the potential delay and potential shortage of influenza vaccine? First, some influenza vaccine manufacturers have reported that one of the three influenza virus components used to make this year's vaccine has not grown as well as the corresponding strain used last year. Secondly, two of the manufacturers licensed to distribute vaccine in the U.S. have been experiencing manufacturing problems. Both manufacturers are working closely with the Food and Drug Administration to address these problems. What is being done to correct the situation? Both manufacturers are working closely with FDA, but implementation of corrective actions will require time for both completion and review by FDA.